Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04301622 · ClinicalTrials.gov registry record
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
A clinical trial of Knee Osteoarthritis and Avascular Necrosis, sponsored by MicroPort Orthopedics.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT04301622: Active study of Knee Osteoarthritis and Avascular Necrosis, sponsored by MicroPort Orthopedics.
NCT04301622 is a study of Knee Osteoarthritis and Avascular Necrosis that is active but no longer recruiting, run by MicroPort Orthopedics. The registered enrollment target is 150 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04301622, a study of Knee Osteoarthritis and Avascular Necrosis, is active but no longer recruiting, sponsored by MicroPort Orthopedics.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® BIOFOAM® Tibia and EVOLUTION® Cruciate Sacrificing/Cruciate Retaining (CS/CR) Porous Femur components, including EVOLUTION® CS tibial inserts. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.
Primary Outcome
Individual component survivorship for tibial base, femoral, and tibial CS insert at specified intervals out to 10 years follow-up.
Conditions Studied
Interventions
- DEVICE Primary Knee implants
Study Locations (1)
Michigan
- Covenant Medical Center - Saginaw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2032-08 |
What the registry record for NCT04301622 still lists
NCT04301622 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (50% lower).
The record links to 6 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Primary Knee implants is the first listed.
NCT04301622 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04301622 about?
NCT04301622 is a clinical study titled "Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur". MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® BIOFOAM® Tibia and EVOLUTION® Cruciate Sacrificing/Cruciate Retaining (CS/CR) Porous Femur components, including EVOLUTION® CS tibial inserts. This type of study is required by regulatory authori...
What is the current status of trial NCT04301622?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2020-02-03. Estimated completion is 2032-08.
What conditions does trial NCT04301622 study?
This clinical trial studies the following conditions: Knee Osteoarthritis, Avascular Necrosis, Degenerative Joint Disease of Knee, Rheumatoid Arthritis of Knee, Correction of Functional Deformity.
What interventions are being tested in trial NCT04301622?
The interventions under investigation include: Primary Knee implants (DEVICE).
Who is sponsoring clinical trial NCT04301622?
This trial is sponsored by MicroPort Orthopedics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04301622 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04301622's enrollment target sits among peer trials
150 34th of 101 higher than 67 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
RECRUITING · Early Phase 1
-
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
RECRUITING · Phase 4
-
Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis
RECRUITING
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI